The global active wound care market has grown strongly in recent years. It will grow from $1.44 billion in 2023 to $1.55 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The historical growth in active wound care can be attributed to various factors. These include the increasing incidence of chronic wounds, a rise in surgical procedures, the prevalence of diabetes, a preference among patients for non-invasive treatments, government initiatives promoting wound care, awareness programs on wound management, and a growing focus on home healthcare. These factors collectively contributed to the development and adoption of active wound care solutions during the historical period.
The global active wound care market is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period for active wound care can be attributed to various factors. These include global initiatives focused on wound healing, the increasing geriatric population, the adoption of personalized medicine approaches, a growing demand for faster healing solutions, and the expanding focus on wound care in developing countries. Major trends expected in the forecast period include the increased adoption of advanced wound dressings, technological innovations in wound care products, the use of bioactive and biodegradable materials, the integration of telemedicine and remote patient monitoring, and considerations for economic and cost-effective solutions within the wound care sector.
The anticipated surge in diabetic patients globally is poised to drive the active wound care market in the foreseeable future. Diabetes, often resulting in elevated blood glucose levels and consequent sores and ulcers, escalates the risk of infections and severe complications, necessitating active wound care treatments. As outlined in the December 2021 report by the International Diabetes Federation (IDF), approximately 537 million adults between 20 and 79 years old were living with diabetes worldwide, expected to increase to 643 million by 2030 and 783 million by 2045, with 6.7 million deaths attributed to diabetes in 2021. Consequently, the escalating diabetic patient count and related fatalities will significantly fuel the growth of the active wound care market.
The growing aging population is expected to be a driving force behind the expansion of the active wound care market. This demographic shift towards an increased percentage of elderly individuals significantly influences healthcare needs, particularly regarding chronic wound management. Conditions like diabetic ulcers, pressure ulcers, and venous leg ulcers become more prevalent with age, emphasizing the importance of active wound care interventions. Technologies in active wound care, encompassing advanced dressings, regenerative therapies, and bioactive materials, cater to the specific needs of elderly patients, expediting wound healing and minimizing associated complications. With the World Health Organization projecting that by 2030, one in six people worldwide will be aged 60 or older, and by 2050, this age group's population will double to reach 2.1 billion, the rise in the aging populace is a key driver of the active wound care market.
Product innovation stands as a prominent trend gaining traction within the active wound care market. Leading companies within this sector are dedicated to developing novel solutions such as regenerative wound therapy and electrical stimulation technology to meet the evolving market demands. For instance, in January 2022, Accel-Heal Technologies Limited introduced Accel-Heal, a wearable electrical stimulation wound therapy device. This device, designed for easy home use, accelerates the healing process of chronic wounds, including challenging ones like diabetic foot ulcers. The innovation allows patients greater flexibility in receiving therapy, and healthcare professionals can integrate this therapy with existing dressing regimens, reducing the need for frequent nursing visits. The introduction of such advancements facilitates wider accessibility to electrical stimulation wound therapy, benefitting both patients and healthcare providers in managing chronic wounds effectively.
Prominent entities in the active wound care sector are actively introducing cutting-edge products leveraging silicone technology to maintain their competitive edge. Silicone technology involves the utilization of synthetic polymer materials known as silicones, comprised of silicon, oxygen, carbon, and hydrogen. Notably, in January 2023, Convatec, a UK-based medical products and technologies company, unveiled ConvaFoam, an advanced foam dressing engineered to meet healthcare providers' and patients' specific needs. ConvaFoam integrates enhanced silicone technology to offer superior adhesion, improved fluid absorption, a prolonged wear duration of seven days, and incorporates a patterned film design aiding in exudate monitoring. Going beyond standard bandages, ConvaFoam simplifies wound care complexities, providing valuable assistance to both patients and healthcare practitioners in addressing prevailing healthcare challenges.
In a strategic move in December 2021, Essity, a Sweden-based hygiene and health company, completed the acquisition of Hydrofera for USD 116 million. This acquisition strategically aligns with Essity's objectives, augmenting its innovation capabilities and expanding its portfolio in the realm of advanced wound care solutions. Hydrofera, a US-based company specializing in manufacturing polyvinyl alcohol (PVA) foam and antibacterial wound dressings, significantly enhances Essity's offerings in the domain of advanced wound care products. The acquisition bolsters Essity's position in the market, fostering innovation and diversification in its range of healthcare solutions.
Major companies operating in the active wound care market report are Smith & Nephew PLC, MiMedx Group Inc., Tissue Regenix Group, Organogenesis Inc., Acell Inc., Integra Life Sciences Holdings Corporation, Solsys Medical LLC, Osiris Therapeutics Inc., Cytori Therapeutics Inc., Human BioSciences Inc., Wright Medical Group NV, Mölnlycke Health Care AB, Medline Industries Inc., AVITA Medical Inc., ConvaTec Inc., Stryker Corporation, 3M Company, Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health Inc., Celularity Inc., Coloplast A/S, Generex Biotechnology Corp., Hill-Rom Holdings Inc., Hollister Incorporated, Johnson & Johnson Inc., Lohmann & Rauscher GmbH & Co. Kg, Medtronic PLC, PAUL HARTMANN AG, Adynxx Inc., Derma sciences Inc., Baxter International Inc., Axio Biosolutions
North America was the largest region in the active wound care market in 2023. The regions covered in the active wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the active wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The main types of active wound care biomaterials include skin substitutes, synthetic skin substitutes, and growth factors. These biomaterials function as barriers against infections, supporting the body's natural healing response for effective wound healing. Active wound care is applied to address various indications such as burns, diabetic foot ulcers, pressure ulcers, and lower limb ulcers, catering to both chronic and acute wounds. End-users of active wound care products span across hospitals, clinics, home care settings, and other healthcare facilities.
This report provides active wound care market statistics, including active wound care industry global market size, regional shares, competitors with an active wound care market share, detailed active wound care market segments, market trends and opportunities, and any further data you may need to thrive in the active wound care industry. This active wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The active wound care market consists of sales of allografts, synthetic skin grafts, xenografts, collagen dressings, and amniotic tissue grafts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The global active wound care market is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The anticipated growth in the forecast period for active wound care can be attributed to various factors. These include global initiatives focused on wound healing, the increasing geriatric population, the adoption of personalized medicine approaches, a growing demand for faster healing solutions, and the expanding focus on wound care in developing countries. Major trends expected in the forecast period include the increased adoption of advanced wound dressings, technological innovations in wound care products, the use of bioactive and biodegradable materials, the integration of telemedicine and remote patient monitoring, and considerations for economic and cost-effective solutions within the wound care sector.
The anticipated surge in diabetic patients globally is poised to drive the active wound care market in the foreseeable future. Diabetes, often resulting in elevated blood glucose levels and consequent sores and ulcers, escalates the risk of infections and severe complications, necessitating active wound care treatments. As outlined in the December 2021 report by the International Diabetes Federation (IDF), approximately 537 million adults between 20 and 79 years old were living with diabetes worldwide, expected to increase to 643 million by 2030 and 783 million by 2045, with 6.7 million deaths attributed to diabetes in 2021. Consequently, the escalating diabetic patient count and related fatalities will significantly fuel the growth of the active wound care market.
The growing aging population is expected to be a driving force behind the expansion of the active wound care market. This demographic shift towards an increased percentage of elderly individuals significantly influences healthcare needs, particularly regarding chronic wound management. Conditions like diabetic ulcers, pressure ulcers, and venous leg ulcers become more prevalent with age, emphasizing the importance of active wound care interventions. Technologies in active wound care, encompassing advanced dressings, regenerative therapies, and bioactive materials, cater to the specific needs of elderly patients, expediting wound healing and minimizing associated complications. With the World Health Organization projecting that by 2030, one in six people worldwide will be aged 60 or older, and by 2050, this age group's population will double to reach 2.1 billion, the rise in the aging populace is a key driver of the active wound care market.
Product innovation stands as a prominent trend gaining traction within the active wound care market. Leading companies within this sector are dedicated to developing novel solutions such as regenerative wound therapy and electrical stimulation technology to meet the evolving market demands. For instance, in January 2022, Accel-Heal Technologies Limited introduced Accel-Heal, a wearable electrical stimulation wound therapy device. This device, designed for easy home use, accelerates the healing process of chronic wounds, including challenging ones like diabetic foot ulcers. The innovation allows patients greater flexibility in receiving therapy, and healthcare professionals can integrate this therapy with existing dressing regimens, reducing the need for frequent nursing visits. The introduction of such advancements facilitates wider accessibility to electrical stimulation wound therapy, benefitting both patients and healthcare providers in managing chronic wounds effectively.
Prominent entities in the active wound care sector are actively introducing cutting-edge products leveraging silicone technology to maintain their competitive edge. Silicone technology involves the utilization of synthetic polymer materials known as silicones, comprised of silicon, oxygen, carbon, and hydrogen. Notably, in January 2023, Convatec, a UK-based medical products and technologies company, unveiled ConvaFoam, an advanced foam dressing engineered to meet healthcare providers' and patients' specific needs. ConvaFoam integrates enhanced silicone technology to offer superior adhesion, improved fluid absorption, a prolonged wear duration of seven days, and incorporates a patterned film design aiding in exudate monitoring. Going beyond standard bandages, ConvaFoam simplifies wound care complexities, providing valuable assistance to both patients and healthcare practitioners in addressing prevailing healthcare challenges.
In a strategic move in December 2021, Essity, a Sweden-based hygiene and health company, completed the acquisition of Hydrofera for USD 116 million. This acquisition strategically aligns with Essity's objectives, augmenting its innovation capabilities and expanding its portfolio in the realm of advanced wound care solutions. Hydrofera, a US-based company specializing in manufacturing polyvinyl alcohol (PVA) foam and antibacterial wound dressings, significantly enhances Essity's offerings in the domain of advanced wound care products. The acquisition bolsters Essity's position in the market, fostering innovation and diversification in its range of healthcare solutions.
Major companies operating in the active wound care market report are Smith & Nephew PLC, MiMedx Group Inc., Tissue Regenix Group, Organogenesis Inc., Acell Inc., Integra Life Sciences Holdings Corporation, Solsys Medical LLC, Osiris Therapeutics Inc., Cytori Therapeutics Inc., Human BioSciences Inc., Wright Medical Group NV, Mölnlycke Health Care AB, Medline Industries Inc., AVITA Medical Inc., ConvaTec Inc., Stryker Corporation, 3M Company, Acelity L.P. Inc., B. Braun Melsungen AG, BSN Medical GmbH, Cardinal Health Inc., Celularity Inc., Coloplast A/S, Generex Biotechnology Corp., Hill-Rom Holdings Inc., Hollister Incorporated, Johnson & Johnson Inc., Lohmann & Rauscher GmbH & Co. Kg, Medtronic PLC, PAUL HARTMANN AG, Adynxx Inc., Derma sciences Inc., Baxter International Inc., Axio Biosolutions
North America was the largest region in the active wound care market in 2023. The regions covered in the active wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the active wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The main types of active wound care biomaterials include skin substitutes, synthetic skin substitutes, and growth factors. These biomaterials function as barriers against infections, supporting the body's natural healing response for effective wound healing. Active wound care is applied to address various indications such as burns, diabetic foot ulcers, pressure ulcers, and lower limb ulcers, catering to both chronic and acute wounds. End-users of active wound care products span across hospitals, clinics, home care settings, and other healthcare facilities.
This report provides active wound care market statistics, including active wound care industry global market size, regional shares, competitors with an active wound care market share, detailed active wound care market segments, market trends and opportunities, and any further data you may need to thrive in the active wound care industry. This active wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The active wound care market consists of sales of allografts, synthetic skin grafts, xenografts, collagen dressings, and amniotic tissue grafts. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Active Wound Care Market Characteristics3. Active Wound Care Market Trends and Strategies31. Global Active Wound Care Market Competitive Benchmarking32. Global Active Wound Care Market Competitive Dashboard33. Key Mergers and Acquisitions in the Active Wound Care Market
4. Active Wound Care Market - Macro Economic Scenario
5. Global Active Wound Care Market Size and Growth
6. Active Wound Care Market Segmentation
7. Active Wound Care Market Regional and Country Analysis
8. Asia-Pacific Active Wound Care Market
9. China Active Wound Care Market
10. India Active Wound Care Market
11. Japan Active Wound Care Market
12. Australia Active Wound Care Market
13. Indonesia Active Wound Care Market
14. South Korea Active Wound Care Market
15. Western Europe Active Wound Care Market
16. UK Active Wound Care Market
17. Germany Active Wound Care Market
18. France Active Wound Care Market
19. Italy Active Wound Care Market
20. Spain Active Wound Care Market
21. Eastern Europe Active Wound Care Market
22. Russia Active Wound Care Market
23. North America Active Wound Care Market
24. USA Active Wound Care Market
25. Canada Active Wound Care Market
26. South America Active Wound Care Market
27. Brazil Active Wound Care Market
28. Middle East Active Wound Care Market
29. Africa Active Wound Care Market
30. Active Wound Care Market Competitive Landscape and Company Profiles
34. Active Wound Care Market Future Outlook and Potential Analysis
35. Appendix
Executive Summary
This report provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on active wound care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for active wound care? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- The impact of higher inflation in many countries and the resulting spike in interest rates.
- The continued but declining impact of covid 19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Report Scope
Markets Covered:
1) By Product: Biomaterials; Skin-substitutes; Synthetic Skin-substitute; Growth Factors2) By Indications: Burns; Diabetic Foot Ulcers; Pressure Ulcers; Lower Limb Ulcers
3) By Application: Chronic Wounds; Acute Wounds
4) By End-User: Hospitals; Clinics; Home Care Settings; Other End-users
Key Companies Mentioned: Smith & Nephew PLC; MiMedx Group Inc.; Tissue Regenix Group; Organogenesis Inc.; Acell Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes
Delivery Format: PDF, Word and Excel Data Dashboard
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Smith & Nephew PLC
- MiMedx Group Inc.
- Tissue Regenix Group
- Organogenesis Inc.
- Acell Inc.
- Integra Life Sciences Holdings Corporation
- Solsys Medical LLC
- Osiris Therapeutics Inc.
- Cytori Therapeutics Inc.
- Human BioSciences Inc.
- Wright Medical Group NV
- Mölnlycke Health Care AB
- Medline Industries Inc.
- AVITA Medical Inc.
- ConvaTec Inc.
- Stryker Corporation
- 3M Company
- Acelity L.P. Inc.
- B. Braun Melsungen AG
- BSN Medical GmbH
- Cardinal Health Inc.
- Celularity Inc.
- Coloplast A/S
- Generex Biotechnology Corp.
- Hill-Rom Holdings Inc.
- Hollister Incorporated
- Johnson & Johnson Inc.
- Lohmann & Rauscher GmbH & Co. Kg
- Medtronic PLC
- PAUL HARTMANN AG
- Adynxx Inc.
- Derma sciences Inc.
- Baxter International Inc.
- Axio Biosolutions
Methodology
LOADING...
